T-DM1: A Successful Case Study of Strategic R&D Partnerships

Drug promiscuity, a phenomenon where a single drug affects more than one cell population, has always proven to be a problem for drug makers today. While drug promiscuity is a desirable attribute in some diseases conferring multiple abnormalities, it is undesirable for certain diseases such as cancer. To put things into perspective, cancer cells are essentially our cells, at least they derived …

Roche Pharmaceuticals produce next generation therapeutic antibodies using today’s cell-culture technology

Roche Pharmaceuticals produce next generation therapeutic antibodies using today's cell-culture technology: Are you looking to deliver next generation therapeutic antibodies using existing cell culture technology? Do you want to reduce costs by utilising existing bio-manufacturing methodologies? Find out how this goal was achieved at the Cell Culture World Congress 2012 where Dr Ingo Gorr, Senior Research Scientist Cell Culture Research …